Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
20.70
-0.91 (-4.21%)
At close: Mar 12, 2026, 4:00 PM EDT
20.60
-0.10 (-0.48%)
After-hours: Mar 12, 2026, 6:54 PM EDT
Denali Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$29.38
Upside
+41.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $32 → $36 | Strong Buy | Maintains | $32 → $36 | +73.91% | Mar 2, 2026 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 24, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +54.59% | Feb 6, 2026 |
| UBS | UBS | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +20.77% | Jan 7, 2026 |
| Wedbush | Wedbush | Buy Maintains $31 → $30 | Buy | Maintains | $31 → $30 | +44.93% | Dec 11, 2025 |
| Wedbush | Wedbush | Buy Maintains $30 → $31 | Buy | Maintains | $30 → $31 | +49.76% | Dec 5, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +54.59% | Dec 5, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $24 → $26 | Buy | Maintains | $24 → $26 | +25.60% | Nov 4, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 8, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $33 → $30 | Buy | Maintains | $33 → $30 | +44.93% | Aug 18, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $28 → $27 | Strong Buy | Maintains | $28 → $27 | +30.43% | May 19, 2025 |
| Baird | Baird | Buy Maintains $30 → $29 | Buy | Maintains | $30 → $29 | +40.10% | May 8, 2025 |
| Wedbush | Wedbush | Buy Maintains $32 → $30 | Buy | Maintains | $32 → $30 | +44.93% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $32 | Strong Buy | Maintains | $80 → $32 | +54.59% | May 7, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +35.27% | Mar 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $41 → $33 | Buy | Initiates | $41 → $33 | +59.42% | Mar 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.